CORTLANDT MANOR, N.Y., Aug. 17, 2011 /PRNewswire/ — Polymedco
is pleased to announce a publication in Epidemiologic Review,
“Organized Colorectal Cancer Screening in Integrated Health Care
Systems” by Theodore R Levin, Laura Jamieson, Daniel A Burley, Juan
Reyes, Michael Oehrli, and Cindy Caldwell (Epidemiol Rev
(2011)33(1);101-110). The publication details the organized
screening program for Colorectal cancer (CRC) at Kaiser Permanente
Northern California (KPNC). The CRC screening program at
KPNC was introduced in the 1960’s with sigmoidoscopy. FIT
(fecal immunochemical test) was introduced in 2004. FIT is
now the screening test of choice for CRC screening in this
organized outreach and inreach program. The HEDIS score for
2007 of 50% for commercial patients jumped dramatically to 69% in
2010. The HEDIS score for 2007 of 50% for Medicare patients
jumped to an incredible 78% in 2010. From 2007 to 2009,
nearly 200 additional localized cancers were detected annually. The
advantages of FIT over the traditional Fecal Occult blood Guaiac
test are as follows: improved patient acceptance so patients
adhere to screening which is in part due to the improved collection
device, fewer samples collected and no dietary restrictions, and
improved specificity; not affected by anticoagulant or non
steroidal medications. Automated specimen processing offers
improved test reliability with no subjectivity, consistent reliable
positivity of the test results from week to week, and quality
assurance to monitor the standards and quality control.
Polymedco Inc. is a leading manufacturer, marketer, and
distributer in the clinical laboratory marketplace. Polymedco
supplies clinical diagnostic test kits and devices that are
specialized in hematology and cancer. We are a world leader in
non-invasive colorectal cancer screening technology, providing the
new standard of care with the
SOURCE